HEADER TRANSFERASE/INHIBITOR 26-SEP-14 4RFM TITLE ITK KINASE DOMAIN IN COMPLEX WITH COMPOUND 1 N-{1-[(1,1-DIOXO-1-THIAN- TITLE 2 2-YL)(PHENYL)METHYL]-1H- PYRAZOL-4-YL}-5,5-DIFLUORO-5A-METHYL-1H,4H, TITLE 3 4AH,5H,5AH,6H-CYCLOPROPA[F]INDAZOLE-3-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ITK/TSK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 357-620); COMPND 5 SYNONYM: INTERLEUKIN-2-INDUCIBLE T-CELL KINASE, IL-2-INDUCIBLE T-CELL COMPND 6 KINASE, KINASE EMT, T-CELL-SPECIFIC KINASE, TYROSINE-PROTEIN KINASE COMPND 7 LYK; COMPND 8 EC: 2.7.10.2; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ITK, EMT, LYK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.A.MCEWAN,J.J.BARKER,C.EIGENBROT REVDAT 3 28-FEB-24 4RFM 1 REMARK SEQADV REVDAT 2 26-AUG-15 4RFM 1 JRNL REVDAT 1 29-APR-15 4RFM 0 JRNL AUTH J.D.BURCH,K.BARRETT,Y.CHEN,J.DEVOSS,C.EIGENBROT,R.GOLDSMITH, JRNL AUTH 2 M.H.ISMAILI,K.LAU,Z.LIN,D.F.ORTWINE,A.A.ZARRIN,P.A.MCEWAN, JRNL AUTH 3 J.J.BARKER,C.ELLEBRANDT,D.KORDT,D.B.STEIN,X.WANG,Y.CHEN, JRNL AUTH 4 B.HU,X.XU,P.W.YUEN,Y.ZHANG,Z.PEI JRNL TITL TETRAHYDROINDAZOLES AS INTERLEUKIN-2 INDUCIBLE T-CELL KINASE JRNL TITL 2 INHIBITORS. PART II. SECOND-GENERATION ANALOGUES WITH JRNL TITL 3 ENHANCED POTENCY, SELECTIVITY, AND PHARMACODYNAMIC JRNL TITL 4 MODULATION IN VIVO. JRNL REF J.MED.CHEM. V. 58 3806 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 25844760 JRNL DOI 10.1021/JM501998M REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0032 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.47 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 12851 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 675 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 686 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 72.20 REMARK 3 BIN R VALUE (WORKING SET) : 0.2700 REMARK 3 BIN FREE R VALUE SET COUNT : 36 REMARK 3 BIN FREE R VALUE : 0.3470 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1977 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 87 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.02000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : -0.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.307 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.232 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.170 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.413 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.933 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2087 ; 0.015 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 1956 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2833 ; 1.776 ; 1.976 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4503 ; 0.916 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 251 ; 7.204 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 95 ;35.965 ;23.474 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 354 ;17.599 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;20.840 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 302 ; 0.105 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2360 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 500 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1001 ; 2.492 ; 2.918 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1000 ; 2.493 ; 2.916 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1250 ; 3.705 ; 4.358 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1251 ; 3.704 ; 4.360 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1086 ; 3.006 ; 3.252 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1085 ; 3.006 ; 3.252 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1580 ; 4.578 ; 4.746 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2390 ; 6.547 ;23.860 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2391 ; 6.546 ;23.867 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 356 A 618 REMARK 3 ORIGIN FOR THE GROUP (A): 9.2519 0.1574 13.9453 REMARK 3 T TENSOR REMARK 3 T11: 0.0359 T22: 0.0454 REMARK 3 T33: 0.0560 T12: 0.0004 REMARK 3 T13: -0.0162 T23: -0.0141 REMARK 3 L TENSOR REMARK 3 L11: 0.7168 L22: 0.6151 REMARK 3 L33: 0.3178 L12: 0.1263 REMARK 3 L13: -0.3278 L23: -0.1433 REMARK 3 S TENSOR REMARK 3 S11: 0.0053 S12: 0.0374 S13: -0.0021 REMARK 3 S21: -0.0531 S22: 0.0221 S23: 0.0190 REMARK 3 S31: -0.0239 S32: -0.0291 S33: -0.0274 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4RFM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-OCT-14. REMARK 100 THE DEPOSITION ID IS D_1000087285. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5419 REMARK 200 MONOCHROMATOR : CONFOCAL OPTICS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13527 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 32.470 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M MAGNESIUM CHLORIDE, 0.1 M REMARK 280 TRIS.HCL (PH 8.0), 20 % PEG 6000, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.78050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 355 REMARK 465 PHE A 506 REMARK 465 VAL A 507 REMARK 465 LEU A 508 REMARK 465 ASP A 509 REMARK 465 ASP A 510 REMARK 465 GLN A 511 REMARK 465 TYR A 512 REMARK 465 THR A 513 REMARK 465 SER A 514 REMARK 465 SER A 515 REMARK 465 THR A 516 REMARK 465 GLY A 517 REMARK 465 THR A 518 REMARK 465 LYS A 519 REMARK 465 GLY A 619 REMARK 465 LEU A 620 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 394 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 395 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 481 NE - CZ - NH1 ANGL. DEV. = -3.4 DEGREES REMARK 500 ARG A 562 NE - CZ - NH2 ANGL. DEV. = 4.4 DEGREES REMARK 500 ARG A 598 NE - CZ - NH2 ANGL. DEV. = 3.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 366 -95.05 -113.16 REMARK 500 LEU A 383 83.35 35.31 REMARK 500 LYS A 385 58.50 -118.97 REMARK 500 MET A 398 -43.94 -133.33 REMARK 500 SER A 399 139.74 92.95 REMARK 500 LEU A 413 79.75 -62.19 REMARK 500 ARG A 481 -7.79 80.34 REMARK 500 ASP A 482 50.13 -152.48 REMARK 500 PHE A 532 22.48 -146.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LEU A 383 ASN A 384 -133.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3P6 A 701 DBREF 4RFM A 357 620 UNP Q08881 ITK_HUMAN 357 620 SEQADV 4RFM GLY A 355 UNP Q08881 EXPRESSION TAG SEQADV 4RFM SER A 356 UNP Q08881 EXPRESSION TAG SEQADV 4RFM SER A 477 UNP Q08881 CYS 477 ENGINEERED MUTATION SEQADV 4RFM ALA A 614 UNP Q08881 GLU 614 ENGINEERED MUTATION SEQADV 4RFM ALA A 617 UNP Q08881 GLU 617 ENGINEERED MUTATION SEQRES 1 A 266 GLY SER VAL ILE ASP PRO SER GLU LEU THR PHE VAL GLN SEQRES 2 A 266 GLU ILE GLY SER GLY GLN PHE GLY LEU VAL HIS LEU GLY SEQRES 3 A 266 TYR TRP LEU ASN LYS ASP LYS VAL ALA ILE LYS THR ILE SEQRES 4 A 266 ARG GLU GLY ALA MET SER GLU GLU ASP PHE ILE GLU GLU SEQRES 5 A 266 ALA GLU VAL MET MET LYS LEU SER HIS PRO LYS LEU VAL SEQRES 6 A 266 GLN LEU TYR GLY VAL CYS LEU GLU GLN ALA PRO ILE CYS SEQRES 7 A 266 LEU VAL PHE GLU PHE MET GLU HIS GLY CYS LEU SER ASP SEQRES 8 A 266 TYR LEU ARG THR GLN ARG GLY LEU PHE ALA ALA GLU THR SEQRES 9 A 266 LEU LEU GLY MET CYS LEU ASP VAL CYS GLU GLY MET ALA SEQRES 10 A 266 TYR LEU GLU GLU ALA SER VAL ILE HIS ARG ASP LEU ALA SEQRES 11 A 266 ALA ARG ASN CYS LEU VAL GLY GLU ASN GLN VAL ILE LYS SEQRES 12 A 266 VAL SER ASP PHE GLY MET THR ARG PHE VAL LEU ASP ASP SEQRES 13 A 266 GLN TYR THR SER SER THR GLY THR LYS PHE PRO VAL LYS SEQRES 14 A 266 TRP ALA SER PRO GLU VAL PHE SER PHE SER ARG TYR SER SEQRES 15 A 266 SER LYS SER ASP VAL TRP SER PHE GLY VAL LEU MET TRP SEQRES 16 A 266 GLU VAL PHE SER GLU GLY LYS ILE PRO TYR GLU ASN ARG SEQRES 17 A 266 SER ASN SER GLU VAL VAL GLU ASP ILE SER THR GLY PHE SEQRES 18 A 266 ARG LEU TYR LYS PRO ARG LEU ALA SER THR HIS VAL TYR SEQRES 19 A 266 GLN ILE MET ASN HIS CYS TRP LYS GLU ARG PRO GLU ASP SEQRES 20 A 266 ARG PRO ALA PHE SER ARG LEU LEU ARG GLN LEU ALA ALA SEQRES 21 A 266 ILE ALA ALA SER GLY LEU HET 3P6 A 701 36 HETNAM 3P6 (4AS,5AR)-N-{1-[(R)-[(2R)-1,1-DIOXIDOTETRAHYDRO-2H- HETNAM 2 3P6 THIOPYRAN-2-YL](PHENYL)METHYL]-1H-PYRAZOL-4-YL}-5,5- HETNAM 3 3P6 DIFLUORO-5A-METHYL-1,4,4A,5,5A,6- HETNAM 4 3P6 HEXAHYDROCYCLOPROPA[F]INDAZOLE-3-CARBOXAMIDE FORMUL 2 3P6 C25 H27 F2 N5 O3 S FORMUL 3 HOH *87(H2 O) HELIX 1 1 ASP A 359 SER A 361 5 3 HELIX 2 2 SER A 399 LEU A 413 1 15 HELIX 3 3 CYS A 442 GLN A 450 1 9 HELIX 4 4 ALA A 455 ALA A 476 1 22 HELIX 5 5 ALA A 484 ARG A 486 5 3 HELIX 6 6 GLU A 492 GLN A 494 5 3 HELIX 7 7 PRO A 521 ALA A 525 5 5 HELIX 8 8 SER A 526 SER A 533 1 8 HELIX 9 9 SER A 536 SER A 553 1 18 HELIX 10 10 SER A 563 THR A 573 1 11 HELIX 11 11 SER A 584 TRP A 595 1 12 HELIX 12 12 ARG A 598 ARG A 602 5 5 HELIX 13 13 ALA A 604 SER A 618 1 15 SHEET 1 A 5 LEU A 363 ILE A 369 0 SHEET 2 A 5 VAL A 377 TRP A 382 -1 O LEU A 379 N GLN A 367 SHEET 3 A 5 ASP A 386 ILE A 393 -1 O ILE A 390 N HIS A 378 SHEET 4 A 5 ILE A 431 GLU A 436 -1 O PHE A 435 N ALA A 389 SHEET 5 A 5 LEU A 421 CYS A 425 -1 N GLY A 423 O VAL A 434 SHEET 1 B 2 CYS A 488 VAL A 490 0 SHEET 2 B 2 ILE A 496 VAL A 498 -1 O LYS A 497 N LEU A 489 CISPEP 1 ASN A 384 LYS A 385 0 6.95 CISPEP 2 ALA A 429 PRO A 430 0 -7.49 SITE 1 AC1 17 ILE A 369 PHE A 374 VAL A 377 ALA A 389 SITE 2 AC1 17 LYS A 391 PHE A 435 GLU A 436 MET A 438 SITE 3 AC1 17 GLU A 439 HIS A 440 GLY A 441 LEU A 489 SITE 4 AC1 17 SER A 499 PHE A 532 HOH A 851 HOH A 884 SITE 5 AC1 17 HOH A 885 CRYST1 40.006 69.561 47.347 90.00 113.39 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024996 0.000000 0.010810 0.00000 SCALE2 0.000000 0.014376 0.000000 0.00000 SCALE3 0.000000 0.000000 0.023011 0.00000